SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-016300
Filing Date
2023-05-01
Accepted
2023-05-01 16:48:39
Documents
12
Period of Report
2023-04-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K fgen-20230429.htm   iXBRL 8-K 59569
  Complete submission text file 0000950170-23-016300.txt   174494

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fgen-20230429_lab.xml EX-101.LAB 12806
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fgen-20230429_pre.xml EX-101.PRE 9453
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fgen-20230429.xsd EX-101.SCH 2469
6 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20230429_htm.xml XML 4509
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 23874554
SIC: 2834 Pharmaceutical Preparations